In a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Alan Fan, MPharm
Advertisement
Articles by Alan Fan, MPharm
Advertisement
Latest Updated Articles
- Persistence With Mirabegron Versus Tolterodine in Patients With Overactive Bladder
Published: April 19th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Weight Loss Drugs On the Horizon: What Pharmacists Should Know
2
Influenza Hospitalizations in Children Reveal Significant Non-respiratory Complications
3
FDA Approves Aflibercept Injection to Treat Patients With Macular Edema Following RVO
4
Kratom Controversies: Exploring Use and Regulation
5
